Optum Ventures added $7.5m to help life sciences data platform Shyft Analytics close a $20m series B round with backing from McKesson and Medidata.
Optum Ventures, a venture capital subsidiary of healthcare provider UnitedHealth Group, invested $7.5m in a $20m round closed by US-based life sciences analytics software developer Shyft Analytics on Wednesday.
The series B round also featured pharmaceutical distributor McKesson, clinical trial analysis software provider Medidata Solutions, Health Enterprise Partners and Milestone Venture Partners.
Shyft has built a cloud data analytics and management platform for life sciences companies that can help accelerate progress in a range of business areas from clinical development…